Executive Decision Defensibility Review
EXECUTIVE DECISION DEFENSIBILITY REVIEW
One material decision. One written executive assessment. Before consequence becomes harder to reverse.
€2,500 · Priority Written Assessment · 5 Business Days
A controlled, author-led written assessment by Ricardo Manuel Machado Ferreira, Creator of the Ferreira Doctrine™ and Architect of Sovereign Decision Science™.
An approved decision can still be indefensible.
The issue is rarely whether a meeting happened, a contract was signed or a risk was recorded.
The harder question is:
Can the organisation explain, in writing, why the decision was defensible when it was made?
The Executive Decision Defensibility Review examines one defined material decision, supplier exposure, contract position or continuity-risk situation and identifies the principal weaknesses that could undermine its later defence.
WHAT THE REVIEW EXAMINES
The assessment focuses on four public-safe dimensions:
EVIDENCE
What written information actually supports the decision — and what material gaps remain?
OWNERSHIP
Who owns the integrated judgement now, not merely the action or process?
AUTHORITY
Can the recognised owner stop, change, fund, escalate or accept the consequence?
CONSEQUENCE
What operational, financial, legal, supplier, continuity, governance or executive exposure could emerge if the decision proves wrong?
Depending on the accepted scope, the review may identify:
→ missing or weak evidence;
→ unresolved assumptions;
→ ownership ambiguity;
→ authority/accountability mismatch;
→ supplier or sub-tier dependency;
→ contract or continuity weakness;
→ technology or ERP/MRP exposure;
→ gaps between contractual remedies and operational recovery;
→ weaknesses in the written decision record;
→ priority questions requiring executive attention.
WHAT YOU RECEIVE
You receive a written PDF executive assessment covering one accepted scope.
Subject to the information available, it may include:
→ Scope Statement — what exactly was reviewed;
→ Information Basis — the written material relied upon and its limitations;
→ Executive Finding — the principal defensibility exposure identified;
→ Evidence Position — material gaps, unresolved claims or assumptions;
→ Ownership & Authority Position — where responsibility or power to act is unclear;
→ Exposure View — relevant supplier, contract, continuity, governance or technology consequence;
→ Priority Written Next Steps — proportionate actions or questions to strengthen the decision position;
→ Boundary Statement — issues requiring specialist legal, financial, regulatory or technical advice.
WHO THIS IS FOR
Designed for leaders responsible for material consequences, including:
CEOs · CFOs · COOs · CROs · Boards · Procurement · Supply Chain · Legal · Finance · Risk · Audit · Compliance · Operations · Technology · ERP/MRP · Transformation · Public Institutions · Regulated Organisations
WHEN TO USE IT
Use the Review when:
→ one material decision already matters;
→ a supplier exposure may affect continuity or financial performance;
→ a contract position has become difficult to defend;
→ assumptions may no longer reflect current conditions;
→ ownership or authority is unclear;
→ evidence exists but its relevance or completeness is uncertain;
→ audit, regulatory or Board scrutiny is foreseeable;
→ leadership needs a written assessment rather than another generic briefing.
DELIVERY
Written-only engagement.
No calls, meetings, workshops or oral interviews are required.
The 5-business-day delivery period begins after:
- the scope is accepted in writing; and
- the agreed non-confidential information has been received.
BEFORE YOU PURCHASE
If you are unsure whether your situation fits the controlled scope, send a short non-confidential enquiry first:
Do not send confidential, privileged, classified or restricted information before the information boundary has been agreed.
ONE PURCHASE COVERS
One purchase covers one:
→ defined decision;
→ supplier exposure;
→ contract position; or
→ continuity-risk situation.
It does not automatically extend to an enterprise-wide review or implementation engagement.
IMPORTANT BOUNDARY
This purchase provides a controlled written executive assessment only.
It does not grant implementation, training, organisational-use, software, derivative, deployment, integration, AI/LLM-ingestion or licensing rights.
It is not legal advice, financial advice, regulatory advice, a statutory audit, an assurance opinion, training, software or implementation consulting.
The public layer explains the exposure.
The Executive Review provides qualified written diagnosis.
Institutional licensing governs controlled organisational use.
Official website:
Review & institutional licensing: